tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Stifel sees opportunity in Glaukos selloff, adds to Select List
PremiumThe FlyStifel sees opportunity in Glaukos selloff, adds to Select List
25d ago
Glaukos Receives Buy Rating from Analyst Ryan Zimmerman Due to Strong Growth and Promising Product Potential
Premium
Ratings
Glaukos Receives Buy Rating from Analyst Ryan Zimmerman Due to Strong Growth and Promising Product Potential
1M ago
Needham medtech & diagnostics analysts hold analyst/industry conference call
Premium
The Fly
Needham medtech & diagnostics analysts hold analyst/industry conference call
1M ago
Glaukos’s iDose Success and Promising Growth Potential Drive Buy Rating
PremiumRatingsGlaukos’s iDose Success and Promising Growth Potential Drive Buy Rating
2M ago
Glaukos Corporation Reports Strong Q2 2025 Growth
Premium
Company Announcements
Glaukos Corporation Reports Strong Q2 2025 Growth
2M ago
Closing Bell Movers: Microsoft jumps 9%, Meta up 12% on earnings beats
Premium
The Fly
Closing Bell Movers: Microsoft jumps 9%, Meta up 12% on earnings beats
2M ago
Glaukos price target raised to $117 from $114 at BTIG
PremiumThe FlyGlaukos price target raised to $117 from $114 at BTIG
3M ago
Glaukos announces E.U. MDR certification for iStent infinite
Premium
The Fly
Glaukos announces E.U. MDR certification for iStent infinite
4M ago
Glaukos Positioned for Growth with Innovative Epioxa Therapy and First-Mover Advantage in Keratoconus Treatment
Premium
Ratings
Glaukos Positioned for Growth with Innovative Epioxa Therapy and First-Mover Advantage in Keratoconus Treatment
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100